Asymmetry Capital Management as of March 31, 2018
Portfolio Holdings for Asymmetry Capital Management
Asymmetry Capital Management holds 36 positions in its portfolio as reported in the March 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ptc Therapeutics I (PTCT) | 10.8 | $8.6M | 319k | 27.06 | |
| Optinose (OPTN) | 8.5 | $6.8M | 339k | 20.02 | |
| Centene Corporation (CNC) | 6.5 | $5.2M | 48k | 106.86 | |
| Jazz Pharmaceuticals (JAZZ) | 5.9 | $4.7M | 31k | 151.00 | |
| Aerie Pharmaceuticals | 4.7 | $3.8M | 70k | 54.25 | |
| UnitedHealth (UNH) | 4.7 | $3.7M | 18k | 214.01 | |
| Insmed (INSM) | 4.6 | $3.7M | 162k | 22.52 | |
| Quest Diagnostics Incorporated (DGX) | 4.0 | $3.2M | 32k | 100.31 | |
| Natera (NTRA) | 3.8 | $3.0M | 326k | 9.27 | |
| Amicus Therapeutics (FOLD) | 3.7 | $2.9M | 195k | 15.04 | |
| Neurocrine Biosciences (NBIX) | 3.1 | $2.5M | 30k | 82.92 | |
| Sarepta Therapeutics (SRPT) | 2.7 | $2.2M | 29k | 74.07 | |
| Heron Therapeutics (HRTX) | 2.7 | $2.1M | 77k | 27.60 | |
| Kala Pharmaceuticals | 2.7 | $2.1M | 134k | 15.83 | |
| Syndax Pharmaceuticals (SNDX) | 2.4 | $1.9M | 136k | 14.23 | |
| Pfizer (PFE) | 2.4 | $1.9M | 53k | 35.50 | |
| Boston Scientific Corporation (BSX) | 2.3 | $1.9M | 68k | 27.32 | |
| La Jolla Pharmaceuticl Com Par | 2.1 | $1.7M | 56k | 29.79 | |
| DURECT Corporation | 2.0 | $1.6M | 753k | 2.14 | |
| Inogen (INGN) | 1.9 | $1.5M | 13k | 122.85 | |
| Tactile Systems Technology, In (TCMD) | 1.7 | $1.3M | 43k | 31.79 | |
| Array BioPharma | 1.7 | $1.3M | 82k | 16.33 | |
| Puma Biotechnology (PBYI) | 1.5 | $1.2M | 18k | 68.06 | |
| Penumbra (PEN) | 1.5 | $1.2M | 10k | 115.67 | |
| Nevro (NVRO) | 1.4 | $1.1M | 13k | 86.65 | |
| Bio-Rad Laboratories (BIO) | 1.4 | $1.1M | 4.5k | 250.06 | |
| Perrigo Company (PRGO) | 1.3 | $1.1M | 13k | 83.31 | |
| Global Blood Therapeutics In | 1.3 | $1.1M | 22k | 48.32 | |
| EXACT Sciences Corporation (EXAS) | 1.3 | $1.0M | 26k | 40.34 | |
| Tivity Health | 1.2 | $975k | 25k | 39.63 | |
| Kadmon Hldgs | 1.1 | $846k | 199k | 4.25 | |
| Endocyte | 1.0 | $831k | 91k | 9.09 | |
| Nucana Plc american depositary shares (NCNA) | 1.0 | $765k | 40k | 18.91 | |
| Regenxbio Inc equity us cm (RGNX) | 0.6 | $478k | 16k | 29.86 | |
| Opko Health (OPK) | 0.6 | $447k | 141k | 3.17 | |
| Molecular Templates | 0.0 | $14k | 1.7k | 8.24 |
